We exist to improve the lives
of everyone affected by epilepsy

Prolonged release acetazolamide capsules out of stock

6 Jul 2017

The following prolonged release acetazolamide capsules are out of stock in the UK:

    • Diamox SR 250mg prolonged release capsules, made by Concordia International
    • Eytazox 250mg prolonged release capsules, made by Auden McKenzie

Both companies expect to have these medicines back in stock at the end of September.

Normal release acetazolamide tablets, called Diamox without SR in the name, are still in stock.

If you take prolonged release acetazolamide, and are due to pick up your next prescription before the end of September, it may not be available. You may need to temporarily switch to the normal release tablets.

If you have any concerns about this, speak to your doctor, epilepsy nurse or pharmacist.

There are no comments yet. Be the first to comment...

Question about your epilepsy?

Use our email helpline service -- your question will be sent directly to our trained helpline advisors who will reply to you. If you post a question about your epilepsy as a comment on a page, it may not be replied to so please use the email helpline service.

Want to talk to other people with epilepsy?

Take a look at forum4e our online community for people with epilepsy. Anyone with epilepsy over the age of 16 can join, from anywhere in the world.

Comment about this page?

We welcome feedback on the content of our website. If you have any comments about the page you were reading, then please complete the form below.

All comments are reviewed by a moderator before appearing on the site. Once the comment appears, your name and comment will be seen by other visitors to the site. Comments will be edited or deleted if they are offensive, libellous, slanderous, abusive, commercial or irrelevant. Comments may also be edited or deleted if they are not relevant to the page on which they are entered.

By making a comment through the website, you allow us to use the comment in our publicity without using your name. If we would like to use your name, we will email you to get your permission.

The content of this field is kept private and will not be shown publicly.
This question is for testing whether you are a human visitor and to prevent automated spam submissions.